July 2, 2020 / 12:48 PM / a month ago

BRIEF-Kitov Pharma Issues CEO Shareholder Letter Providing Business Update

July 2 (Reuters) - Kitov Pharma Ltd:

* KITOV PHARMA ISSUES CEO SHAREHOLDER LETTER PROVIDING BUSINESS UPDATE

* KITOV PHARMA LTD - AS OF END OF JUNE 2020, HAD OVER $60 MILLION IN CASH

* KITOV PHARMA LTD - CONSENSI EXPECTED TO BEGIN GENERATING ROYALTY REVENUE FOR KITOV THIS YEAR

* KITOV PHARMA LTD - CURRENT CASH RUNWAY IS EXPECTED TO SUPPORT OUR CURRENTLY PLANNED ACTIVITIES INTO AT LEAST 2024

* KITOV PHARMA LTD - BELIEVE WE ARE WELL-FUNDED TO EXECUTE OUR STRATEGIC PLANS

* KITOV PHARMA LTD - EXPECT TO RECEIVE MILESTONE & ROYALTY REVENUES OF BETWEEN $28 MILLION & $36 MILLION FROM 2020 THROUGH 2022, IN AGREEMENT FOR CONSENSI Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below